CELL LINES PHARMACEUTICAL RESEARCH

Brand Owner (click to sort) Address Description
CELL GENESYS Cell Genesys, Inc. 111 Barclay Boulevard Lincolnshire IL 60069 cell lines for pharmaceutical research and development;CELL GENESIS;biochemicals; namely, monoclonal antibodies and fragments thereof for pharmaceutical and biological research and development;CELL;
CELL GENESYS Cell Genesys, Inc. 111 Barclay Boulevard Lincolnshire IL 60069 cell lines for pharmaceutical research and development; and cell line products for pharmaceutical research and development, namely cell line pharmaceutical proteins and preparations for the treatment of cancer, autoimmune diseases, infectious diseases, inflammatory diseases and genetic diseases;biochemicals; namely, monoclonal antibodies and fragments thereof for pharmaceutical and biological research and development;CELL;
XENOMOUSE Xenotech, Inc. 6701 Kaiser Drive Fremont CA 94555 cell lines for pharmaceutical research and development; animal embryos for laboratory use;XENO-MOUSE;biochemicals; namely, monoclonal antibodies and fragments thereof for pharmaceutical and biological research and development;live laboratory animals for pharmaceutical research and development;product development and product development consultation regarding pharmaceutical and biological products;
XENOTECH Xenotech, Inc. 6701 Kaiser Drive Fremont CA 94555 cell lines for pharmaceutical research and development; animal embryos for laboratory use;XENO-TECH;biochemicals, namely, monoclonal antibodies and fragments thereof for pharmaceutical and biological research and development;product development and product development consultation regarding pharmaceutical and biological products;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The invention provides cell lines which are useful for the rapid detection of enteroviruses. In particular, the invention provides transgenic African green monkey kidney cell lines and buffalo green monkey kidney cell lines. The invention provides cell lines which have increased sensitivity to infection by enteroviruses in single-cell type and mixed-cell type cultures compared to other cell types which are currently used for enterovirus detection. The cells of the invention also are permissive to infection by a larger number of enteroviruses as compared to the cell type from which they were derived.